Follow us on your favorite social media platforms !

DEA
Culture

First Federal Lawsuit Spawns from FDA Approval of Cannabis-Based CBD

In the wake of the June 25th decision by the Federal Drug Administration to approve a cannabis-based CBD-rich epilepsy medication from GW Pharma, a new lawsuit has been filed by a medical marijuana user against the federal government.

The plaintiff is essentially calling the FDA as her first witness and this has the federal government tiptoeing through a minefield of their own making.

Read More »
Education

CBD Treatment Approved by FDA Could Carry Cannabis to Rescheduling

The FDA’s Center for Drug Evaluation and Research has approved the legal use of CBD for patients ages 2 and up who suffer from very specific conditions: Dravet Syndrome (DS) and Lennox-Gastaut Syndrome (LGS), two severe forms of childhood-onset epilepsy. With so much public support in the US for cannabis legalization – not just CBD legalization – the time is right for a major overhaul.

Read More »